In vitro susceptibilities of Bartonella henselae, B. quintana, B. elizabethae, Rickettsia rickettsii, R. conorii, R. akari, and R. prowazekii to Macrolide antibiotics as determined by immunofluorescent-antibody analysis of infected vero cell monolayers

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 3, 1997, Pages 578-582

  Ives, Timothy J ^a,b   Manzewitsch, Pablo ^c   Regnery, Russell L ^c   Butts, John D ^d   Kebede, Mizanu ^b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d UNIVERSITY OF NORTH CAROLINA HOSPITALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CLARITHROMYCIN; DIRITHROMYCIN; ERYTHROMYCIN; MACROLIDE; ROXITHROMYCIN;

ANIMAL CELL; ANIMAL TISSUE; ANTIBIOTIC SENSITIVITY; ARTICLE; BARTONELLACEAE; CONCENTRATION RESPONSE; DRUG POTENCY; IMMUNOFLUORESCENCE TEST; INHIBITION KINETICS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; RICKETTSIACEAE; VERO CELL;

EID: 0031020487     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.3.578     Document Type: Article

References (45)

1. Adal, K. A., C. J. Cockerell, and W. A. Petri. 1994. Cat scratch disease, bacillary angiomatosis, and other infections due to Rochalimaea. N. Engl. J. Med. 330:1509-1515.
2. Anderson, B., K. Sims, R. Regnery, L. Robinson, M. J. Schmidt, S. Goral, C. Hager, and K. Edwards. 1994. Detection of Rochalimaea henselae DNA in specimens from cat scratch disease patients by PCR. J. Clin. Microbiol. 32:942-948.
3. Batterman, H. J., J. A. Peek, J. S. Loutit, S. Falkow, and L. S. Tompkins. 1995. Bartonella henselae and Bartonella quintana adherence to and entry into cultured human epithelial cells. Infect. Immun. 63:4553-4556.
4. Bergogne-Berezin, E. 1987. Tissue distribution of roxithromycin. J. Antimicrob. Chemother. 20(Suppl. B):113-120.
5. Birkett, D. J., R. A. Robson, N. Grgurinovich, and A. Tonkin. 1990. Single oral dose pharmacokinetics of erythromycin and roxithromycin and the effects of chronic dosing. Ther. Drug Monit. 12:65-71.
6. Chu, S. Y., D. S. Wilson, D. R. Guay, and C. Craft. 1992. Clarithromycin pharmacokinetics in healthy young and elderly volunteers. J. Clin. Pharmacol. 32:1045-1049.
7. Chun, A. H. C., and J. A. Seitz. 1977. Pharmacokinetics and biological activity of erythromycin. Infection 5:S14-S22.
8. Daly, J. S., M. G. Worthington, D. J. Brenner, C. W. Moss, D. G. Hollis, R. S. Weyant, A. G. Steigerwalt, R. E. Weaver, M. I. Daneshvar, and S. P. O'Connor. 1993. Rochalimaea elizabethae sp. nov. isolated from a patient with endocarditis. J. Clin. Microbiol. 31:872-881.
9. Dolan, M. J., M. T. Wong, R. L. Regnery, J. H. Jorgensen, M. Garcia, J. Peters, and D. Drehner. 1993. Syndrome of Rochalimaea henselae adenitis suggesting cat scratch disease. Ann. Intern. Med. 118:331-336.
10. Drancourt, M., and D. Raoult. 1989. In vitro susceptibilities of Rickettsia rickettsii and Rickettsia conorii to roxithromycin and pristinamycin. Antimicrob. Agents Chemother. 33:2146-2148.
11. Fishbein, D. B., M. G. Frontini, R. Giles, and L. L. Vernon. 1990. Fatal cases of Rocky Mountain spotted fever in the United States, 1981-1988. Ann. N. Y. Acad. Sci. 590:246-247.
12. Foulds, G., R. M. Shepard, and R. B. Johnson. 1990. The pharmacokinetics of azithromycin in human serum and tissue. J. Antimicrob. Chemother. 25:S73-S82.
13. García, I., A. Pascual, M. C. Guzman, and E. J. Perea. 1992. Uptake and intracellular activity of sparfloxacin in human polymorphonuclear leukocytes and tissue culture cells. Antimicrob. Agents Chemother. 36:1053-1056.
14. Gemmell, C. G., and A. O'Dowd. 1983. Regulation of protein A biosynthesis in Staphylococcus aureus by certain antibiotics: its effect on phagocytosis by leukocytes. J. Antimicrob. Chemother. 12:587-597.
15. Girard, A. E., C. R. Cimochowski, and J. A. Faiella. 1990. Correlation of increased azithromvcin levels with phagocyte infiltration into sites of infection, abstr. 762, p. 213. Program and abstracts of the 30th Interscience Conference on Antimicrobial Agents and Chemotherapy, Atlanta, Ga.
16. Gladue, R. P., G. M. Bright, R. E. Isaacson, and M. F. Newborg. 1989. In vitro and in vivo uptake of azithromycin (CP-62,993) by phagocytic cells: possible mechanism of delivery and release at sites of infection. Antimicrob. Agents Chemother. 33:277-282.
17. Gladue, R. P., and M. E. Snider. 1990. Intracellular accumulation of azithromycin by cultured human fibroblasts. Antimicrob. Agents Chemother. 34: 1056-1060.
18. Hand, W. L., N. L. King-Thompson, and D. Johnson. 1984. Influence of bactericidal-antibiotic interactions on subsequent antimicrobial activity of alveolar macrophages. J. Infect. Dis. 149:271-276.
19. Heinzen, R. A., S. F. Hayes, M. G. Peacock, and T. Hackstadt. 1993. Directional actin polymerization associated with spotted fever group rickettsia infection of Vero cells. Infect. Immun. 61:1926-1935.
20. Ishiguro, M., H. Koga, S. Kohno, et al. 1989. Penetration of macrolides into human polymorphonuclear leukocytes. J. Antimicrob. Chemother. 24:719-730.
21. Koehler, J. E., F. D. Quinn, T. G. Berger, P. E. LeBoit, and J. W. Tappero. 1992. Isolation of Rochalimaea species from cutaneous and osseous lesions of bacillary angiomatosis. N. Engl. J. Med. 327:1625-1631.
22. Koehler, J. E., and J. W. Tappero. 1993. Bacillary angiomatosis and bacillary peliosis in patients infected with human immunodeficiency virus. Clin. Infect. Dis. 17:612-624.
23. Margileth, A. M. 1992. Antibiotic therapy for cat-scratch disease: clinical study of therapeutic outcome in 268 patients and a review of the literature. Pediatr. Infect. Dis. J. 11:474-478.
24. Martin, J. R., P. Johnson, and M. F. Miller. 1985. Uptake, accumulation, and egress of erythromycin by tissue culture cells of human origin. Antimicrob. Agents Chemother. 27:314-319.
25. Maurin, M., and D. Raoult. 1993. In vitro susceptibilities of spotted fever group rickettsiae and Coxiella burnetti to clarithromycin. Antimicrob. Agents Chemother. 37:2633-2637.
26. Maurin, M., and D. Raoult. 1993. Antimicrobial susceptibilities of Rochalimaea quintana, Rochalimaea vinsonii, and the newly recognized Rochalimaea henselae. J. Antimicrob. Chemother. 32:587-594.
27. Maurin, M., S. Gasquet, C. Ducco, and D. Raoult. 1995. MICs of 28 antibiotic compounds for 14 Bartonella (formerly Rochalimaea) isolates. Antimicrob. Agents Chemother. 39:2387-2391.
28. Mor, N., and L. Heifets. 1993. MICs and MBCs of clarithromycin against Mycobacterium avium within human macrophages. Antimicrob. Agents Chemother. 37:111-114.
29. Mtairag, E. M., H. Abdelghaffar, C. Douhet, and M. T. Labro. 1995. Role of extracellular calcium in in vitro uptake and intraphagocytic location of macrolides. Antimicrob. Agents Chemother. 39:1676-1682.
30. Munoz-Espin, T., P. Lopez-Pares, E. Espejo-Arenas, et al. 1986. Erythromycin versus tetracycline for treatment of Mediterranean spotted fever. Arch. Dis. Child. 61:1027-1029.
31. Musso, D., M. Drancourt, and D. Raoult. 1995. Lack of bactericidal effect of antibiotics except aminoglycosides on Bartonella (Rochalimaea) henselae. J. Antimicrab. Chemother. 36:101-108.
32. Myers, W. F., D. F. Grossman, and C. L. Wisseman. 1984. Antibiotic susceptibility patterns in Rochalimaea quintana, the agent of trench fever. Antimicrob. Agents Chemother. 25:690-693.
33. Ormsbee, R. A. 1985. Rickettsiac as organisms. Acta Virol. 29:432-448.
34. Ramsey, P. G., and O. W. Press. 1984. Successful therapy of Rocky Mountain 'spotless' fever. West. J. Med. 140:94-96.
35. Raoult, D., P. Roussellier, G. Vestris, and J. Tamalet. 1987. In vitro antibiotic susceptibility of Rickettsia ricketisii and Rickettsia conorii: plaque assay and microplaque colorimetric assay. J. Infect. Dis. 155:1059-1062.
36. Raoult, D., P. Roussellier, and J. Tamalet. 1988. In vitro evaluation of josamycin, spiramycin, and erythromycin against Rickettsia rickettsii and R. conorii. Antimicrob. Agents Chemother. 32:255-256.
37. Raoult, D., and M. Drancourt. 1991. Antimicrobial therapy of rickettsial diseases. Antimicrob. Agents Chemother. 35:2457-2462.
38. Regnery, R. L., B. E. Anderson, J. E. Clarridge, M. C. Rodriguez-Barradas, D. C. Jones, and J. H. Carr. 1992. Characterization of a novel Rochalimaea species, R. henselae sp. nov., isolated from blood of a febrile, human immunodeficiency virus-positive patient. J. Clin. Microbiol. 30:265-274.
39. Scaglione, F., G. Demartini, S. Dugnani, et al. 1993. A new model examining intracellular and extracellular activity of amoxicillin, azithromycin and clarithromycin in infected cells. Chemotherapy 39:416-423.
40. Shaked, Y. Y., Y. Samra, M. K. Maeir, and E. Rubinstein. 1988. Murine typhus and spotted fever in Israel in the eighties: retrospective analysis. Infection 16:283-287.
41. Sides, G. D., B. J. Cerimele, H. R. Black, U. Busch, and K. A. DeSante. 1993. Pharmacokinetics of dirithromycin. J. Antimicrob. Chemother. 31:S65-S75.
42. Welch, D. F., D. A. Pickett, L. N. Slater, A. G. Steigerwalt, and D. J. Brenner. 1992. Rochalimaea henselae sp. nov., a cause of septicemia, bacillary angiomatosis, and parenchymal bacillary peliosis. J. Clin. Microbiol. 30:275-280.
43. Wisseman, C. L., Jr., A. D. Waddell, and W. T. Walsh. 1974. In vitro studies of the action of antibiotics on Rickettsia prowazekii by two basic methods of cell culture. J. Infect. Dis. 130:564-574.
44. Wisseman, C. L., Jr., E. A. Edlinger, A. D. Waddell, and M. R. Jones. 1976. Infection cycle of Rickettsia ricketisii in chicken embryo and L-929 cells in culture. Infect. Immun. 14:1052-1064.
45. Wisseman, C. L., and S. V. Ordonez. 1986. Actions of antibiotics on Rickettsia rickettsii. J. Infect. Dis. 153:626-628.